3,0
6 giu 2026
Dipendente attuale, più di 8 anni
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
- exciting technology - incredibly smart scientists - opportunity to be at forefront of exciting new therapeutics
Svantaggi
- shifting budgets and priorities on a quarterly basis, makes it difficult to execute long term strategic plans (especially if a quarter has poor performance due to constant restructuring)